Karius is a series c plus startup based in United States. 1 investor tracked.
Based in the United States, Karius is a startup founded in 2014. Brouky records 4 investors associated with the company.
Karius is a clinical metagenomics company that sequences and analyzes microbial cell-free DNA (mcfDNA) from patient samples to detect pathogens and inform infectious disease diagnosis and treatment. Their platform provides clinicians with rapid, comprehensive genomic insights into potential infections.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.